Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Dolby Laboratories, Inc. (DLB)?

Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the third quarter. Among them, Valeant and Micron ranked among the top 30 picks and both lost around 20%. Citigroup, which was the third most popular stock, lost 10% amid uncertainty regarding the interest rates. Nevertheless, our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted returns. This is why following the smart money sentiment is a useful tool at identifying the next stock to invest in.

Dolby Laboratories, Inc. (NYSE:DLB) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 21 hedge funds’ portfolios at the end of September. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Nice Systems Ltd (ADR) (NASDAQ:NICE), Retail Properties of America Inc (NYSE:RPAI), and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to gather more data points.

Follow Dolby Laboratories Inc. (NYSE:DLB)
Trade (NYSE:DLB) Now!

Keeping this in mind, we’re going to check out the key action surrounding Dolby Laboratories, Inc. (NYSE:DLB).

How have hedgies been trading Dolby Laboratories, Inc. (NYSE:DLB)?

Of the funds tracked by Insider Monkey, MFP Investors, managed by Michael Price, holds the largest position in Dolby Laboratories, Inc. (NYSE:DLB). MFP Investors has a $33.4 million position in the stock, comprising 5% of its 13F portfolio. Coming in second is Nantahala Capital Management, led by Wilmot B. Harkey and Daniel Mack, holding a $28.5 million position; 3.9% of its 13F portfolio is allocated to the stock. Other professional money managers that are bullish contain Chuck Royce’s Royce & Associates, Peter S. Park’s Park West Asset Management and Jim Simons’s Renaissance Technologies.

Interestingly, Paul Marshall and Ian Wace’s Marshall Wace LLP dropped the biggest investment of the “upper crust” of funds watched by Insider Monkey, totaling about $2.3 million in stock. Neil Chriss’s fund, Hutchin Hill Capital, also dumped its stock, about $2 million worth. These transactions are interesting, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

Let’s now review hedge fund activity in other stocks – not necessarily in the same industry as Dolby Laboratories, Inc. (NYSE:DLB) but similarly valued. These stocks are Nice Systems Ltd (ADR) (NASDAQ:NICE), Retail Properties of America Inc (NYSE:RPAI), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and Owens-Illinois Inc (NYSE:OI). This group of stocks’ market valuations resemble DLB’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
NICE 19 170490 -1
RPAI 17 116250 1
ACAD 24 933851 -2
OI 24 813587 -11

As you can see these stocks had an average of 21 hedge funds with bullish positions and the average amount invested in these stocks was $509 million. That figure was $162 million in DLB’s case. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is the most popular stock in this table. On the other hand Retail Properties of America Inc (NYSE:RPAI) is the least popular one with only 17 bullish hedge fund positions. Dolby Laboratories, Inc. (NYSE:DLB) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. In this regard ACAD might be a better candidate to consider a long position.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!